Insider filing · CADL
Seshu Tyagarajan
Chief Technology Officer
profile →
Candel Therapeutics, Inc.
CADL · Healthcare · 16 filings in 24 months
ticker →
Seshu Tyagarajan sold $276K of Candel Therapeutics (CADL)
Executed Mar 17 2025, disclosed Mar 19 2025, 2 days later.
Value, as filed
$276K
31,278 sh × $8.82
Executed
Mar 17 2025
the trade date, as filed
Disclosed
Mar 19 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
STSeshu Tyagarajan (Chief Technology Officer) filed 4 Form 4 reports in the past 24 months (0 purchases, 4 sales, 1 filed past the two-business-day deadline), most often in Candel Therapeutics, Inc. (CADL). The largest single filing was $276K of CADL (31,278 sh × $8.82, as filed), executed Mar 17 2025.
The name
CADLHealthcare · Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Seshu Tyagarajan in CADL
CADLSALE
Candel Therapeutics, Inc.
$276K31,278 sh × $8.82
Exec Mar 17 2025
Filed Mar 20 2025 · 5:30 PM ET † CADLSALE Candel Therapeutics, Inc. $104K
14,322 sh × $7.23
Exec Jan 15 2025
Filed Jan 17 2025 · 5:30 PM ET CADLSALE Candel Therapeutics, Inc. $120K
14,545 sh × $8.22
Exec Jan 8 2025
Filed Jan 10 2025 · 5:30 PM ET